GlassScriptPhysician profile
J Michael West
NPI 1710024195
$3,885.60
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,406 · 2020: $966 · 2021: $1,232 · 2022: $282.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $944.69 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $941.19 | 2019-2022 | |
| Ucb, INC. | $313.40 | 2019-2020 | |
| Janssen Biotech, INC. | $280.48 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $248.21 | 2019-2022 | |
| Gilead Sciences, INC. | $174.62 | 2019-2021 | |
| Allergan, INC. | $111.31 | 2019 | |
| Ferring Pharmaceuticals INC. | $109.62 | 2020-2022 | |
| Ironwood Pharmaceuticals, INC | $88.66 | 2019-2022 | |
| Intercept Pharmaceuticals, INC. | $86.25 | 2019-2021 | |
| Celgene Corporation | $85.78 | 2021 | |
| Janssen Scientific Affairs, LLC | $84.85 | 2019 | |
| Merck Sharp & Dohme LLC | $62.16 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $56.80 | 2020-2021 | |
| Pfizer INC. | $44.59 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $38.76 | 2020-2021 | |
| Evoke Pharma, INC. | $36.44 | 2020-2022 | |
| Romark Laboratories, Lc | $33.01 | 2019 | |
| Shionogi INC | $30.83 | 2019 | |
| Qol Medical, LLC | $25.28 | 2019 | |
| Daiichi Sankyo INC. | $23.97 | 2020 | |
| Vivus LLC | $21.55 | 2021 | |
| Shire North American Group INC | $19.38 | 2019 | |
| Redhill Biopharma INC. | $12.59 | 2020 | |
| Alfasigma USA, INC. | $11.18 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.